Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8119655 Kinase inhibitors

Patent 8119655 was granted and assigned to Takeda Pharmaceutical Company on February, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

Takeda Pharmaceutical Company

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Bheema R. Paraselli0

Jeffrey A. Stafford0

Michael B. Wallace0

Nicholas Scorah0

Qing Dong0

Date of Patent

February 21, 2012

0

Patent Application Number

115398570

Date Filed

October 9, 2006

0

Patent Citations Received

US Patent 12024517 Salts of an FGFR inhibitor

0

US Patent 11702412 Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

0

US Patent 11891365 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

0

US Patent 11903949 Fluoro beta-carboline compounds

0

Patent Primary Examiner

0

Patent abstract

Compounds, pharmaceutical compositions, kits and methods are provided for use with kinases that comprise a compound selected from the group consisting of:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8119655 Kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool